Zymeworks Statistics
NASDAQ: ZYMEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
25.26-1.27 (-4.79%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Zymeworks by the numbers
Zymeworks has a market capitalization of $1.81 billion based on 71.20M shares outstanding. With trailing EPS of $-2.02, Zymeworks is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.4% below its 50-day average and 0.7% above its 200-day average.
Average daily trading volume is 699.88K shares, or about $17.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ZYME valuation vs. peer median
| Metric | ZYME | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.81B | $1.81B | -0% |
| Avg. volume | 699.88K | 1.28M | -45% |
Peer median across 8 companies: URGN, XNCR, BHVN, TRVI, GENB, NUVB, ADRX, PVLA.
Valuation
- Market cap
- $1.81B
- Forward P/E
- 28.97
- Price / sales (latest FY)
- 17.10
- EPS (TTM)
- $-2.02
- Shares outstanding
- 71.20M
Price and trading
- Previous close
- 26.53
- Open
- 26.24
- Day range
- 25.00 – 26.24
- 52-week range
- 16.00 – 31.34
- 52-week change
- +51.44%
- Beta
- —
- Volume
- 1.26M
- Average volume
- 699.88K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 1.81B
- Forward Pe
- 28.97
- Eps
- -2.02
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 31.34
- Week52 Low
- 16.00
- Avg Volume
- 699.88K
- Shares Outstanding
- 71.20M
- Ma50
- 26.43
- Ma200
- 25.09
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -19.40%
- Pct From52w Low
- 57.85%